ir.syndax.com
Analyst Coverage – Syndax
http://ir.syndax.com/analysts.cfm
Annual Reports and Proxies. Syndax Pharmaceuticals, Inc. is covered by the following analysts. Robert C. Hazlett. Joel Beatty, MD. Michael G. King, Jr. 2017 Syndax Terms of Use.
ir.syndax.com
Ownership Profile – Syndax
http://ir.syndax.com/ownership-profile.cfm
Annual Reports and Proxies. Data is unavailable at this time. 2017 Syndax Terms of Use.
ir.syndax.com
Investment Calculator – Syndax
http://ir.syndax.com/calculator.cfm
Annual Reports and Proxies. Calculate Current Value and Shares Since: March 3, 2016. There are no adjustments for your investment. 2017 Syndax Terms of Use.
ir.syndax.com
Events & Presentations – Syndax
http://ir.syndax.com/events.cfm
Annual Reports and Proxies. 29th Annual ROTH Conference. 29th Annual ROTH Conference. Please sign up for Email alerts. Oppenheimer 27th Annual Healthcare Conference. Oppenheimer 27th Annual Healthcare Conference. Please sign up for Email alerts. File is in Briefcase. Cowen and Company 37th Annual Health Care Conference. Syndax Fourth Quarter 2016 Conference Call. File is in Briefcase. Add file to Briefcase. 2017 Syndax Terms of Use.
ir.syndax.com
Investors – Syndax
http://ir.syndax.com/index.cfm
Annual Reports and Proxies. Syndax Pharmaceuticals, Inc. is a late-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Through our pipeline agents, entinostat, a late stage, class 1 specific HDAC inhibitor and SNDX-6352, a phase 1 anti-CSF-1R monoclonal antibody, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax corporate headquarters are in Waltham, MA.
ir.syndax.com
Board of Directors – Syndax
http://ir.syndax.com/directors.cfm
Annual Reports and Proxies. Dennis G. Podlesak. Chairman of the Board of Directors. Briggs W. Morrison, M.D. Chief Executive Officer and Director. Fabrice Egros, Ph.D. Luke Evnin, Ph.D. Kim P Kamdar, Ph.D. Ivor Royston, M.D. George W. Sledge Jr., M.D. Dennis G. Podlesak. Chairman of the Board of Directors. Mr Podlesak received a B.A. and an M.B.A. from Pepperdine University, and has completed postgraduate studies at the Wharton School, University of Pennsylvania. Member of the Compensation Committee.
ir.syndax.com
Press Releases – Syndax
http://ir.syndax.com/releases.cfm
Annual Reports and Proxies. Syndax Pharmaceuticals Reports Fourth Quarter and Year-end 2016 Financial Results and Provides Clinical and Business Update. File is in Briefcase. Syndax Pharmaceuticals Announces Participation at Three Upcoming Investor Conferences. File is in Briefcase. Syndax to Announce Fourth Quarter and Year-end 2016 Financial Results and Host Conference Call and Webcast on March 2, 2017. File is in Briefcase. Syndax Appoints Richard P. Shea as Chief Financial Officer. 10 results per page.
ir.syndax.com
Syndax Third Quarter 2016 Conference Call – Syndax
http://ir.syndax.com/eventdetail.cfm?EventID=176508
Annual Reports and Proxies. Syndax Third Quarter 2016 Conference Call. File is in Briefcase. 2017 Syndax Terms of Use.
ir.syndax.com
FAQs – Syndax
http://ir.syndax.com/faq.cfm
Annual Reports and Proxies. On what stock exchange are Syndax Pharmaceuticals, Inc.'s shares traded, and what is the ticker symbol? Our common stock is traded on the NASDAQ Global Select Market under the symbol “SNDX.”. When was Syndax Pharmaceuticals, Inc.'s Initial Public Offering? Our common stock first began trading on the NASDAQ Global Select Market in March 2016. How can I buy or sell Syndax Pharmaceuticals, Inc.'s common stock? Where is Syndax Pharmaceuticals, Inc.'s corporate headquarters? Does S...
ir.syndax.com
Annual Reports and Proxies – Syndax
http://ir.syndax.com/annuals-proxies.cfm
Annual Reports and Proxies. Annual Reports and Proxies. An annual report is not available at this time. Anyone seeking further information about the Company is welcome to review the prospectus on our SEC filings. 2017 Syndax Terms of Use.